Identification of galectin-7 as a potential biomarker for esophageal squamous cell carcinoma by proteomic analysis

BMC Cancer

Volumn 10, Issue , 2010, Pages

  Zhu, Xi ^a   Ding, Ming ^c   Yu, Mei Lan ^c   Feng, Ming Xiang ^b   Tan, Li Jie ^b   Zhao, Fu Kun ^a,c  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b FUDAN UNIVERSITY   (China)

^c ZHEJIANG SCI TECH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GALECTIN 7; GALECTIN; LGALS7 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DOWN REGULATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS MUCOSA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; TISSUE MICROARRAY; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; WESTERN BLOTTING; AMINO ACID SEQUENCE; CANCER STAGING; CELL DIFFERENTIATION; CHEMISTRY; ESOPHAGUS TUMOR; MASS SPECTROMETRY; METHODOLOGY; MIDDLE AGED; MOLECULAR GENETICS; PATHOLOGY; SQUAMOUS CELL CARCINOMA; TANDEM MASS SPECTROMETRY;

AGED; AMINO ACID SEQUENCE; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; ESOPHAGEAL NEOPLASMS; FEMALE; GALECTINS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM STAGING; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TANDEM MASS SPECTROMETRY; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 77954638391     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-10-290     Document Type: Article

References (47)

1. Pisani P, Parkin DM, Bray F, Ferlay J. Erratum: Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer, 83, 18-29 (1999). Int J Cancer 1999, 83(6):870-873. 10.1002/(SICI)1097-0215(19991210)83:6<870::AID-IJC35>3.0.CO;2-9, 10602059.
2. Lehrbach DM, Nita ME, Cecconello I. Molecular aspects of esophageal squamous cell carcinoma carcinogenesis. Arq Gastroenterol 2003, 40(4):256-261. 10.1590/S0004-28032003000400011, 15264049.
3. Katlic MR, Wilkins EW, Grillo HC. Three decades of treatment of esophageal squamous carcinoma at the Massachusetts General Hospital. J Thorac Cardiovasc Surg 1990, 99(5):929-938.
4. Hagymasi K, Tulassay Z. Genetic background of esophageal squamous cell carcinoma. Orv Hetil 2007, 148(38):1795-1800. 10.1556/OH.2007.28200, 17872334.
5. Tachibana M, Kinugasa S, Hirahara N, Yoshimura H. Lymph node classification of esophageal squamous cell carcinoma and adenocarcinoma. Eur J Cardiothorac Surg 2008, 34(2):427-431. 10.1016/j.ejcts.2008.04.022, 18502142.
6. Sung HJ, Cho JY. Biomarkers for the lung cancer diagnosis and their advances in proteomics. BMB Rep 2008, 41(9):615-625.
7. Cheung PK, Woolcock B, Adomat H, Sutcliffe M, Bainbridge TC, Jones EC, Webber D, Kinahan T, Sadar M, Gleave ME, et al. Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis. Cancer Res 2004, 64(17):5929-5933. 10.1158/0008-5472.CAN-04-1216, 15342369.
8. Ebert MP, Kruger S, Fogeron ML, Lamer S, Chen J, Pross M, Schulz HU, Lage H, Heim S, Roessner A, et al. Overexpression of cathepsin B in gastric cancer identified by proteome analysis. Proteomics 2005, 5(6):1693-1704. 10.1002/pmic.200401030, 15789341.
9. Roessler M, Rollinger W, Mantovani-Endl L, Hagmann ML, Palme S, Berndt P, Engel AM, Pfeffer M, Karl J, Bodenmuller H, et al. Identification of PSME3 as a novel serum tumor marker for colorectal cancer by combining two-dimensional polyacrylamide gel electrophoresis with a strictly mass spectrometry-based approach for data analysis. Mol Cell Proteomics 2006, 5(11):2092-2101. 10.1074/mcp.M600118-MCP200, 16893879.
10. Hatakeyama H, Kondo T, Fujii K, Nakanishi Y, Kato H, Fukuda S, Hirohashi S. Protein clusters associated with carcinogenesis, histological differentiation and nodal metastasis in esophageal cancer. Proteomics 2006, 6(23):6300-6316. 10.1002/pmic.200600488, 17133371.
11. Nishimori T, Tomonaga T, Matsushita K, Oh-Ishi M, Kodera Y, Maeda T, Nomura F, Matsubara H, Shimada H, Ochiai T. Proteomic analysis of primary esophageal squamous cell carcinoma reveals downregulation of a cell adhesion protein, periplakin. Proteomics 2006, 6(3):1011-1018. 10.1002/pmic.200500262, 16400690.
12. Zhang LY, Ying WT, Mao YS, He HZ, Liu Y, Wang HX, Liu F, Wang K, Zhang DC, Wang Y, et al. Loss of clusterin both in serum and tissue correlates with the tumorigenesis of esophageal squamous cell carcinoma via proteomics approaches. World J Gastroenterol 2003, 9(4):650-654.
13. Contu SS, Contu PC, Damin DC, Fagundes RB, Bevilacqua F, Rosa AS, Prolla JC, Moreira LF. pRB expression in esophageal mucosa of individuals at high risk for squamous cell carcinoma of the esophagus. World J Gastroenterol 2007, 13(11):1728-1731.
14. Qi Y, Chiu JF, Wang L, Kwong DL, He QY. Comparative proteomic analysis of esophageal squamous cell carcinoma. Proteomics 2005, 5(11):2960-2971. 10.1002/pmic.200401175, 15986332.
15. Chen Y, Ouyang GL, Yi H, Li MY, Zhang PF, Li C, Li JL, Liu YF, Chen ZC, Xiao ZQ. Identification of RKIP as an invasion suppressor protein in nasopharyngeal carcinoma by proteomic analysis. J Proteome Res 2008, 7(12):5254-5262. 10.1021/pr800602c, 19367706.
16. Liu FT. Galectins: a new family of regulators of inflammation. Clin Immunol 2000, 97(2):79-88. 10.1006/clim.2000.4912, 11027447.
17. Liu FT, Patterson RJ, Wang JL. Intracellular functions of galectins. Biochim Biophys Acta 2002, 1572(2-3):263-273.
18. Hernandez JD, Baum LG. Ah, sweet mystery of death! Galectins and control of cell fate. Glycobiology 2002, 12(10):127R-136R. 10.1093/glycob/cwf081, 12244068.
19. Rabinovich GA. Galectins: an evolutionarily conserved family of animal lectins with multifunctional properties; a trip from the gene to clinical therapy. Cell Death Differ 1999, 6(8):711-721. 10.1038/sj.cdd.4400535, 10467344.
20. Yan S, Zhou C, Lou X, Xiao Z, Zhu H, Wang Q, Wang Y, Lu N, He S, Zhan Q, et al. PTTG overexpression promotes lymph node metastasis in human esophageal squamous cell carcinoma. Cancer Res 2009, 69(8):3283-3290. 10.1158/0008-5472.CAN-08-0367, 19351864.
21. Madsen P, Rasmussen HH, Flint T, Gromov P, Kruse TA, Honore B, Vorum H, Celis JE. Cloning, expression, and chromosome mapping of human galectin-7. J Biol Chem 1995, 270(11):5823-5829. 10.1074/jbc.270.11.5823, 7534301.
22. Magnaldo T, Bernerd F, Darmon M. Galectin-7, a human 14-kDa S-lectin, specifically expressed in keratinocytes and sensitive to retinoic acid. Dev Biol 1995, 168(2):259-271. 10.1006/dbio.1995.1078, 7729568.
23. Magnaldo T, Fowlis D, Darmon M. Galectin-7, a marker of all types of stratified epithelia. Differentiation 1998, 63(3):159-168. 10.1046/j.1432-0436.1998.6330159.x, 9697310.
24. Barondes SH, Cooper DN, Gitt MA, Leffler H. Galectins. Structure and function of a large family of animal lectins. J Biol Chem 1994, 269(33):20807-20810.
25. Hughes RC. Secretion of the galectin family of mammalian carbohydrate-binding proteins. Biochim Biophys Acta 1999, 1473(1):172-185.
26. Saussez S, Cucu DR, Decaestecker C, Chevalier D, Kaltner H, Andre S, Wacreniez A, Toubeau G, Camby I, Gabius HJ, et al. Galectin 7 (p53-induced gene 1): a new prognostic predictor of recurrence and survival in stage IV hypopharyngeal cancer. Ann Surg Oncol 2006, 13(7):999-1009. 10.1245/ASO.2006.08.033, 16788763.
27. Saussez S, Decaestecker C, Lorfevre F, Chevalier D, Mortuaire G, Kaltner H, Andre S, Toubeau G, Gabius HJ, Leroy X. Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopharyngeal and laryngeal squamous cell carcinomas. Histopathology 2008, 52(4):483-493. 10.1111/j.1365-2559.2008.02973.x, 18315601.
28. Chen J, He QY, Yuen AP, Chiu JF. Proteomics of buccal squamous cell carcinoma: the involvement of multiple pathways in tumorigenesis. Proteomics 2004, 4(8):2465-2475. 10.1002/pmic.200300762, 15274141.
29. Demers M, Biron-Pain K, Hebert J, Lamarre A, Magnaldo T, St-Pierre Y. Galectin-7 in lymphoma: elevated expression in human lymphoid malignancies and decreased lymphoma dissemination by antisense strategies in experimental model. Cancer Res 2007, 67(6):2824-2829. 10.1158/0008-5472.CAN-06-3891, 17363605.
30. Langbein S, Brade J, Badawi JK, Hatzinger M, Kaltner H, Lensch M, Specht K, Andre S, Brinck U, Alken P, et al. Gene-expression signature of adhesion/growth-regulatory tissue lectins (galectins) in transitional cell cancer and its prognostic relevance. Histopathology 2007, 51(5):681-690. 10.1111/j.1365-2559.2007.02852.x, 17927590.
31. Ramagli LS. Quantifying protein in 2-D PAGE solubilization buffers. Methods Mol Biol 1999, 112:99-103.
32. Berkelman TST. 2-D Electrophoresis: using Immobilized pH Gradients; Principles & Methods. 1998, Uppsala, Sweden: Amersham Biosciences.
33. Yan JX, Wait R, Berkelman T, Harry RA, Westbrook JA, Wheeler CH, Dunn MJ. A modified silver staining protocol for visualization of proteins compatible with matrix-assisted laser desorption/ionization and electrospray ionization-mass spectrometry. Electrophoresis 2000, 21(17):3666-3672. 10.1002/1522-2683(200011)21:17<3666::AID-ELPS3666>3.0.CO;2-6, 11271485.
34. Tian HY, Zhang KH, Gao X, Lei WW, Zhang L, Yu ML, Song JG, Zhao FK. Comparative proteomic analysis of cell cycle-dependent apoptosis induced by transforming growth factor-beta. Biochim Biophys Acta 2009,
35. Shen D, Nooraie F, Elshimali Y, Lonsberry V, He J, Bose S, Chia D, Seligson D, Chang HR, Goodglick L. Decreased expression of annexin A1 is correlated with breast cancer development and progression as determined by a tissue microarray analysis. Hum Pathol 2006, 37(12):1583-1591. 10.1016/j.humpath.2006.06.001, 16949910.
36. Garcia Pedrero JM, Fernandez MP, Morgan RO, Herrero Zapatero A, Gonzalez MV, Suarez Nieto C, Rodrigo JP. Annexin A1 down-regulation in head and neck cancer is associated with epithelial differentiation status. Am J Pathol 2004, 164(1):73-79. 1602219, 14695321.
37. Pawlak G, McGarvey TW, Nguyen TB, Tomaszewski JE, Puthiyaveettil R, Malkowicz SB, Helfman DM. Alterations in tropomyosin isoform expression in human transitional cell carcinoma of the urinary bladder. Int J Cancer 2004, 110(3):368-373. 10.1002/ijc.20151, 15095301.
38. Janke J, Schluter K, Jandrig B, Theile M, Kolble K, Arnold W, Grinstein E, Schwartz A, Estevez-Schwarz L, Schlag PM, et al. Suppression of tumorigenicity in breast cancer cells by the microfilament protein profilin 1. J Exp Med 2000, 191(10):1675-1686. 10.1084/jem.191.10.1675, 2193149, 10811861.
39. Srisomsap C, Subhasitanont P, Otto A, Mueller EC, Punyarit P, Wittmann-Liebold B, Svasti J. Detection of cathepsin B up-regulation in neoplastic thyroid tissues by proteomic analysis. Proteomics 2002, 2(6):706-712. 10.1002/1615-9861(200206)2:6<706::AID-PROT706>3.0.CO;2-E, 12112852.
40. Rorive S, Eddafali B, Fernandez S, Decaestecker C, Andre S, Kaltner H, Kuwabara I, Liu FT, Gabius HJ, Kiss R, et al. Changes in galectin-7 and cytokeratin-19 expression during the progression of malignancy in thyroid tumors: diagnostic and biological implications. Mod Pathol 2002, 15(12):1294-1301. 10.1097/01.MP.0000037306.19083.28, 12481010.
41. Cada Z, Chovanec M, Smetana K, Betka J, Lacina L, Plzak J, Kodet R, Stork J, Lensch M, Kaltner H, et al. Galectin-7: will the lectin's activity establish clinical correlations in head and neck squamous cell and basal cell carcinomas?. Histol Histopathol 2009, 24(1):41-48.
42. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B. A model for p53-induced apoptosis. Nature 1997, 389(6648):300-305. 10.1038/38525, 9305847.
43. Bernerd F, Sarasin A, Magnaldo T. Galectin-7 overexpression is associated with the apoptotic process in UVB-induced sunburn keratinocytes. Proc Natl Acad Sci USA 1999, 96(20):11329-11334. 10.1073/pnas.96.20.11329, 18033, 10500176.
44. Kopitz J, Andre S, von Reitzenstein C, Versluis K, Kaltner H, Pieters RJ, Wasano K, Kuwabara I, Liu FT, Cantz M, et al. Homodimeric galectin-7 (p53-induced gene 1) is a negative growth regulator for human neuroblastoma cells. Oncogene 2003, 22(40):6277-6288. 10.1038/sj.onc.1206631, 13679866.
45. Saussez S, Cludts S, Capouillez A, Mortuaire G, Smetana K, Kaltner H, Andre S, Leroy X, Gabius HJ, Decaestecker C. Identification of matrix metalloproteinase-9 as an independent prognostic marker in laryngeal and hypopharyngeal cancer with opposite correlations to adhesion/growth-regulatory galectins-1 and -7. Int J Oncol 2009, 34(2):433-439.
46. Ostergaard M, Rasmussen HH, Nielsen HV, Vorum H, Orntoft TF, Wolf H, Celis JE. Proteome profiling of bladder squamous cell carcinomas: identification of markers that define their degree of differentiation. Cancer Res 1997, 57(18):4111-4117.
47. Shibata T, Noguchi T, Takeno S, Takahashi Y, Fumoto S, Kawahara K. Impact of nuclear galectin-3 expression on histological differentiation and vascular invasion in patients with esophageal squamous cell carcinoma. Oncol Rep 2005, 13(2):235-239.